Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
Clinical trial NCT00909532 · COMPLETED
Trial details
- NCT number
- NCT00909532
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-07-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.